Sphera Funds Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-326,660
Closed -$6.28M 124
2019
Q1
$6.28M Sell
326,660
-379,879
-54% -$6.12M 0.57% 37
2018
Q4
$10.1M Buy
706,539
+7,500
+1% +$149K 1.14% 23
2018
Q3
$14.6M Buy
699,039
+392,384
+128% +$9.29M 1.67% 12
2018
Q2
$7.26M Sell
306,655
-173,345
-36% -$3.48M 1% 24
2018
Q1
$7.01M Buy
480,000
+250,000
+109% +$4.08M 1.06% 24
2017
Q4
$3.72M Sell
230,000
-220,000
-49% -$2.6M 0.44% 56
2017
Q3
$6.29M Sell
450,000
-100,000
-18% -$997K 0.9% 26
2017
Q2
$4.86M Sell
550,000
-400,000
-42% -$2.81M 0.83% 32
2017
Q1
$6.15M Sell
950,000
-100,000
-10% -$507K 1.2% 20
2016
Q4
$3.85M Buy
1,050,000
+650,000
+163% +$1.92M 0.98% 28
2016
Q3
$1.3M Hold
400,000
0.21% 90
2016
Q2
$928K Buy
+400,000
New +$1.34M 0.24% 79
2015
Q3
Sell
-245,000
Closed -$995K 149
2015
Q2
$995K Sell
245,000
-55,000
-18% -$225K 0.1% 119
2015
Q1
$1.15M Buy
+300,000
New +$1.3M 0.12% 133
2014
Q4
Sell
-534,050
Closed -$1.99M 158
2014
Q3
$1.99M Sell
534,050
-15,950
-3% -$53.9K 0.25% 85
2014
Q2
$2.01M Buy
550,000
+250,000
+83% +$918K 0.49% 49
2014
Q1
$1.26M Buy
+300,000
New +$1.49M 0.29% 75

Other funds holding IMMU

Sphera Funds Management's IMMU Position: Q2 2019 in Review

Sphera Funds Management sold out of Immunomedics Inc (IMMU) in Q2 2019, closing a stake of 326,660 shares — an estimated $6.28M sold.

Sphera Funds Management first reported a position in IMMU in Q1 2014 and held it in 17 quarters. The position peaked at $14.6M in Q3 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q2 2019.

  • Sphera Funds Management reported no remaining Immunomedics Inc position as of Q2 2019 after selling out during the quarter.
  • Sphera Funds Management sold 326,660 Immunomedics Inc shares in Q2 2019, an estimated $6.28M.
  • Sphera Funds Management first reported a position in Immunomedics Inc in Q1 2014 and held it in 17 quarters.
  • Sphera Funds Management's Immunomedics Inc position peaked at $14.6M in Q3 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.